Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;12(3):294-304.
doi: 10.11909/j.issn.1671-5411.2015.03.013.

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem

Affiliations
Review

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem

Bharathi Upadhya et al. J Geriatr Cardiol. 2015 May.

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) is the most common form of HF in older adults, and is increasing in prevalence as the population ages. Furthermore, HFpEF is increasing out of proportion to HF with reduced EF (HFrEF), and its prognosis is worsening while that of HFrEF is improving. Despite the importance of HFpEF, our understanding of its pathophysiology is incomplete, and optimal treatment remains largely undefined. A cardinal feature of HFpEF is reduced exercise tolerance, which correlates with symptoms as well as reduced quality of life. The traditional concepts of exercise limitations have focused on central dysfunction related to poor cardiac pump function. However, the mechanisms are not exclusive to the heart and lungs, and the understanding of the pathophysiology of this disease has evolved. Substantial attention has focused on defining the central versus peripheral mechanisms underlying the reduced functional capacity and exercise tolerance among patients with HF. In fact, physical training can improve exercise tolerance via peripheral adaptive mechanisms even in the absence of favorable central hemodynamic function. In addition, the drug trials performed to date in HFpEF that have focused on influencing cardiovascular function have not improved exercise capacity. This suggests that peripheral limitations may play a significant role in HF limiting exercise tolerance, a hallmark feature of HFpEF.

Keywords: Exercise intolerance; Heart failure; Peripheral limitations; Skeletal muscle.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Survival of patients in the cardiovascular health study.
Control: nested case controls without heart failure; DHF: heart failure with a normal ejection fraction; Asx LVD: reduced ejection fraction with no symptoms of heart failure; SHF: systolic heart failure. Modified from: Gottdiener, et al.
Figure 2.
Figure 2.. Magnetic resonance imaging axial image of the mid-thigh in a patient with HFpEF and HC.
Red = skeletal muscle; green = IMF; blue = subcutaneous fat; purple = femoral cortex; yellow = femoral medulla. IMF (green) is substantially increased in the patient with HFpEF compared with the HC despite similar subcutaneous fat. HC: healthy controls; HFpEF: heart failure with preserved ejection fraction; IMF: intermuscular fat.
Figure 3.
Figure 3.. Relationship of capillary-to-fiber ratio (A) and percentage of type I muscle fibers (B) with peak O2 uptake (VO2) in older patients with heart failure with preserved ejection fraction (▪) and age-matched healthy control subjects (▴).

References

    1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209. - PMC - PubMed
    1. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456–2467. - PubMed
    1. Kitzman DW, Hundley WG, Brubaker P, et al. A randomized, controlled, double-blinded trial of enalapril in older patients with heart failure and preserved ejection fraction; effects on exercise tolerance, and arterial distensibility. Circ Heart Fail. 2010;3:477–485. - PMC - PubMed
    1. Edelmann F, Aldo-DHF investigators Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013;309:781–791. - PubMed
    1. Pitt B, Pfeffer M, Assmann S, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370:1383–1392. - PubMed

LinkOut - more resources